Our study was not sufficiently powered to determine whether a variant allele fraction or tumor biopsy site (brain metastasis vs primary tumor vs extracranial metastasis) influences the effects of ATM variants on post-SRS outcomes. This evidence concerns the gene ATM and neoplasm.